Immunodeficiency in children starting antiretroviral therapy in low-, middle- and high-income countries

Lignende værker

• Response to Doherty et al: Early initiation of antiretroviral therapy amongst young children: a long way to go
  af: Koller, Manuel, et al.
  Udgivet: (2015)
• Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration
  af: Leroy, Valeriane, et al.
  Udgivet: (2013)
• Time‐varying age‐ and CD4‐stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium
  af: Desmonde, Sophie, et al.
  Udgivet: (2020)
• Authors’ response: Immunodeficiency at Start of Combination Antiretroviral Therapy 2002–2010: Steady Improvement
  af: Koller, Manuel, et al.
  Udgivet: (2015)
• Access to antiretroviral therapy in HIV-infected children aged 0–19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004–2015: A prospective cohort study
  af: Desmonde, Sophie, et al.
  Udgivet: (2018)